Northwest Biotherapeutics, Inc.
NWBO
$0.23
$0.000.09%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.56M | 4.32M | 2.78M | 2.18M | 2.94M |
| Total Receivables | 311.00K | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.33M | 1.84M | 1.91M | 1.89M | 2.25M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.20M | 6.16M | 4.69M | 4.06M | 5.19M |
|
|
|||||
| Total Current Assets | 7.20M | 6.16M | 4.69M | 4.06M | 5.19M |
| Net Property, Plant & Equipment | 21.14M | 21.10M | 20.53M | 20.38M | 21.84M |
| Long-term Investments | 626.00K | 626.00K | 626.00K | 626.00K | 626.00K |
| Goodwill | 626.00K | 626.00K | 626.00K | 626.00K | 626.00K |
| Total Other Intangibles | 1.29M | 1.29M | 1.29M | 1.29M | 1.29M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 358.00K | 370.00K | 367.00K | 365.00K | 374.00K |
| Total Assets | 30.61M | 29.55M | 27.51M | 26.73M | 29.32M |
|
|
|||||
| Total Accounts Payable | 26.88M | 23.66M | 20.75M | 16.97M | 17.91M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 13.57M | 16.31M | 19.64M | 14.19M | 7.58M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 27.23M | 25.93M | 24.78M | 20.52M | 21.46M |
| Total Finance Division Other Current Liabilities | 20.24M | 18.02M | 17.89M | 16.60M | 12.61M |
| Total Other Current Liabilities | 20.24M | 18.02M | 17.89M | 16.60M | 12.61M |
| Total Current Liabilities | 87.91M | 83.92M | 83.06M | 68.27M | 59.56M |
|
|
|||||
| Total Current Liabilities | 87.91M | 83.92M | 83.06M | 68.27M | 59.56M |
| Long-Term Debt | 31.81M | 22.94M | 20.11M | 28.30M | 24.47M |
| Short-term Debt | 13.57M | 16.31M | 19.64M | 14.19M | 7.58M |
| Capital Leases | 4.45M | 4.62M | 4.47M | 4.44M | 4.83M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.70M | 4.70M | 4.70M | 4.70M | 4.70M |
| Total Liabilities | 125.86M | 116.18M | 112.34M | 105.71M | 93.56M |
|
|
|||||
| Common Stock & APIC | 1.40B | 1.38B | 1.36B | 1.35B | 1.34B |
| Retained Earnings | -1.51B | -1.48B | -1.46B | -1.44B | -1.42B |
| Treasury Stock & Other | -1.30M | -1.93M | 1.32M | 2.96M | -108.00K |
| Total Common Equity | -108.65M | -100.39M | -99.48M | -94.49M | -80.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 13.40M | 13.75M | 14.64M | 15.51M | 15.88M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 13.40M | 13.75M | 14.64M | 15.51M | 15.88M |
|
|
|||||
| Total Common Equity | -108.65M | -100.39M | -99.48M | -94.49M | -80.12M |
| Total Preferred Equity | 13.40M | 13.75M | 14.64M | 15.51M | 15.88M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -95.25M | -86.64M | -84.84M | -78.98M | -64.24M |
|
|
|||||